Stempfle H U, Angermann C E, Kraml P, Schütz A, Kemkes B M, Theisen K
Department of Internal Medicine (Medizinische Klinik, Klinikum Innenstadt), University of Munich, Germany.
J Am Coll Cardiol. 1993 Jul;22(1):310-7. doi: 10.1016/0735-1097(93)90849-v.
The aim of this study was to assess 1) whether quantitative ultrasound tissue analysis by serial measurements of myocardial echo amplitudes can detect and monitor the onset and degree of acute cardiac rejection, as well as its resolution of acute rejection during treatment, and 2) whether changes in myocardial echo amplitudes are modified by repeat additional rejection episodes.
Previous experimental studies, all involving heterotopic heart transplantation, have consistently shown reproducible alterations in myocardial echo amplitude during acute rejection episodes untreated by immunosuppressive agents.
Two-dimensional echocardiographic long-axis views were obtained daily under strict standardization in 12 dogs after heterotopic cervical heart transplantation (mean survival time 16.1 days) and digitized into a 256 x 256 x 8 matrix. Myocardial echo amplitudes were analyzed by gray level histogram statistics in regions of interest (45 x 12 pixels) within the proximal septum and posterior wall and correlated with the results of daily transmural myocardial biopsies. Maintenance immunosuppressive therapy consisted of cyclosporine, azathioprine and steroids. Additive steroids were given during acute cardiac rejection.
All dogs experienced at least one moderate or severe episode of acute cardiac rejection. Successful resolution and repeat acute rejection were observed in three dogs. On 65 days, the left ventricular biopsy specimens showed no evidence of acute rejection. Mild acute rejection was present on 36, moderate on 29 and severe rejection on 40 days. End-diastolic mean (+/- SD) gray level increased progressively from 100.7 +/- 20.4 for no acute cardiac rejection to 113.8 +/- 23.1 for mild rejection (p = NS vs. no rejection) to 126.0 +/- 16.1 for moderate rejection (p < 0.01) and to 136.3 +/- 12.6 for severe rejection (p < 0.01). In each individual dog, a correlation between daily measurements of mean gray levels and histologic cardiac rejection grades was found (rmean = 0.80 +/- 0.14 [range 0.57 to 0.97], n = 12). In three dogs with transient complete histologic resolution of acute cardiac rejection, mean gray level did not return to values before rejection (108.0 +/- 15.4 vs. 87.2 +/- 8.4). The subsequent second episode of rejection was characterized by higher gray level values than those associated with the first rejection episode (141.3 +/- 14.4 vs. 124.3 +/- 20.9).
Acute cardiac rejection is associated with a progressive increase in mean gray level. Changes in myocardial echo amplitudes in individuals may thus prove a useful tool for the noninvasive detection and monitoring of acute rejection. Increased mean gray level values after resolution of rejection may indicate persistent structural tissue abnormalities after rejection and demonstrate the need to define new baseline values after histologic resolution of an acute rejection episode.
本研究旨在评估:1)通过连续测量心肌回声幅度进行定量超声组织分析能否检测和监测急性心脏排斥反应的发生、程度以及治疗期间急性排斥反应的消退情况;2)重复发生的额外排斥反应是否会改变心肌回声幅度。
以往所有涉及异位心脏移植的实验研究均一致表明,在未接受免疫抑制剂治疗的急性排斥反应发作期间,心肌回声幅度会出现可重复的改变。
对12只经异位颈部心脏移植的犬(平均存活时间16.1天),每天在严格标准化条件下获取二维超声心动图长轴视图,并数字化为256×256×8矩阵。通过近端室间隔和后壁内感兴趣区域(45×12像素)的灰度直方图统计分析心肌回声幅度,并与每日透壁心肌活检结果相关联。维持性免疫抑制治疗包括环孢素、硫唑嘌呤和类固醇。在急性心脏排斥反应期间给予额外的类固醇。
所有犬均经历至少一次中度或重度急性心脏排斥反应发作。在3只犬中观察到成功消退和重复急性排斥反应。在第65天,左心室活检标本未显示急性排斥反应迹象。在第36天存在轻度急性排斥反应,第29天为中度,第40天为重度。舒张末期平均(±标准差)灰度从无急性心脏排斥反应时的100.7±20.4逐渐增加到轻度排斥反应时的113.8±23.1(与无排斥反应相比,p =无显著性差异),中度排斥反应时为126.0±16.1(p < 0.01),重度排斥反应时为136.3±12.6(p < 0.01)。在每只犬中,均发现平均灰度的每日测量值与组织学心脏排斥反应分级之间存在相关性(r平均 = 0.80±0.14 [范围0.57至0.97],n = 12)。在3只急性心脏排斥反应组织学短暂完全消退的犬中,平均灰度未恢复到排斥反应前的值(108.0±15.4对87.2±8.4)。随后的第二次排斥反应发作的特征是灰度值高于第一次排斥反应发作时的值(141.3±14.4对124.3±20.9)。
急性心脏排斥反应与平均灰度的逐渐增加相关。因此,个体心肌回声幅度的变化可能是用于无创检测和监测急性排斥反应的有用工具。排斥反应消退后平均灰度值增加可能表明排斥反应后存在持续性结构组织异常,并表明在急性排斥反应发作组织学消退后需要确定新的基线值。